INVESTIGATING DECOY-RESISTANT IL-18 PLUS IMMUNE CHECKPOINT INHIBITORS IN PRECLINICAL MURINE AND EX VIVO PATIENT-DERIVED MODELS OF RENAL CELL CARCINOMA
$1,214,375FY2024Defense Health AgencyDOD
Yale Univ
Investigators
View source on USAspending →INVESTIGATING DECOY-RESISTANT IL-18 PLUS IMMUNE CHECKPOINT INHIBITORS IN PRECLINICAL MURINE AND EX VIVO PATIENT-DERIVED MODELS OF RENAL CELL CARCINOMA · GrantIndex